Precision Oncology and Regenerative Strategies in Esophageal Cancer: From Tumor Cell Plasticity and Microenvironmental Networks to Functional Models and Tissue Repair

Esophageal cancer (EC), comprising esophageal squamous cell carcinoma and esophageal adenocarcinoma, remains a highly aggressive malignancy characterized by substantial intratumoral heterogeneity, cellular plasticity, therapeutic resistance, and poor clinical outcomes. Increasing evidence indicates that EC progression is governed not only by tumor-intrinsic genetic alterations but also by dynamic interactions among signaling networks, metabolic and epigenetic programs, cancer stem-like states, stromal and immune cells, extracellular matrix, vasculature, neural components, and the microbiome. In this review, we synthesize advances in the cellular and molecular biology of EC and discuss their implications for precision therapeutic strategies, with emphasis on oncogenic signaling, pathway rewiring, tumor–microenvironment interactions, cancer stem-cell plasticity, and emerging biomarker platforms, including multi-omics, liquid biopsy, extracellular vesicles, single-cell sequencing, and spatial transcriptomics. We further examine patient-derived organoids, organoid–immune co-culture systems, three-dimensional bioprinted tumor models, and computational approaches as functional platforms for investigating tumor heterogeneity, therapeutic response, and treatment resistance. Beyond tumor control, tissue-engineering and regenerative strategies for repairing treatment-associated mucosal injury, fibrosis, stricture, and tissue loss are discussed. Importantly, regenerative interventions require careful oncologic consideration because pathways involved in tissue repair, stem-cell activation, angiogenesis, and extracellular-matrix remodeling may influence residual malignant cells. Finally, we highlight the convergence of precision oncology, functional tumor modeling, regenerative medicine, and artificial intelligence, while addressing challenges in standardization, validation, scalability, regulation, and clinical translation.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-12
DOI
https://doi.org/10.20944/preprints202611.1338.v1
Primary Topic
Esophageal Cancer Research and Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Precision Oncology and Regenerative Strategies in Esophageal Cancer: From Tumor Cell Plasticity and Microenvironmental Networks to Functional Models and Tissue Repair

Stefano Cacciatore, Ali Merito Ali, Ibrahim Houmed Aboubaker, Fatouma Mohamed Abdoul‐Latif et al.
Preprints.org
Esophageal Cancer Research and Treatment
preprint

Precision Oncology and Regenerative Strategies in Esophageal Cancer: From Tumor Cell Plasticity and Microenvironmental Networks to Functional Models and Tissue Repair

Stefano Cacciatore, Ali Merito Ali, Ibrahim Houmed Aboubaker, Fatouma Mohamed Abdoul‐Latif, Saredo Mohamed Hassan, Rohit Kumar
preprint en

Abstract

Esophageal cancer (EC), comprising esophageal squamous cell carcinoma and esophageal adenocarcinoma, remains a highly aggressive malignancy characterized by substantial intratumoral heterogeneity, cellular plasticity, therapeutic resistance, and poor clinical outcomes. Increasing evidence indicates that EC progression is governed not only by tumor-intrinsic genetic alterations but also by dynamic interactions among signaling networks, metabolic and epigenetic programs, cancer stem-like states, stromal and immune cells, extracellular matrix, vasculature, neural components, and the microbiome. In this review, we synthesize advances in the cellular and molecular biology of EC and discuss their implications for precision therapeutic strategies, with emphasis on oncogenic signaling, pathway rewiring, tumor–microenvironment interactions, cancer stem-cell plasticity, and emerging biomarker platforms, including multi-omics, liquid biopsy, extracellular vesicles, single-cell sequencing, and spatial transcriptomics. We further examine patient-derived organoids, organoid–immune co-culture systems, three-dimensional bioprinted tumor models, and computational approaches as functional platforms for investigating tumor heterogeneity, therapeutic response, and treatment resistance. Beyond tumor control, tissue-engineering and regenerative strategies for repairing treatment-associated mucosal injury, fibrosis, stricture, and tissue loss are discussed. Importantly, regenerative interventions require careful oncologic consideration because pathways involved in tissue repair, stem-cell activation, angiogenesis, and extracellular-matrix remodeling may influence residual malignant cells. Finally, we highlight the convergence of precision oncology, functional tumor modeling, regenerative medicine, and artificial intelligence, while addressing challenges in standardization, validation, scalability, regulation, and clinical translation.

Preprints.org
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon